Anavex Life Sciences Corp (AVXL)

[bas2020]

Speaking of that n you keep bringing up... and the statement you made, below, after you've done your homework...

Simple answer, a huge placebo effect in Alzheimer’s – bigger than in other conditions.

So, given that the placebo effect in AD is “huge”, what is your best estimate for the # of placebo-group patients experiencing a placebo effect in the P2b/3 trial, that met the threshold level, in terms of a percentage range?

After all the research done, I'm sure you have some idea of what that range might be. One would think it would be greater than 10%, right?

We're waiting...